☰

Mark H. Pollack - Publications

Affiliations: 
Psyciatry Massachusetts General Hospital & Harvard Medical School, Boston, MA, United States 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

315 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Voigt RM, Zalta AK, Raeisi S, Zhang L, Brown JM, Forsyth CB, Boley RA, Held P, Pollack MH, Keshavarzian A. Abnormal intestinal milieu in post-traumatic stress disorder is not impacted by treatment that improves symptoms. American Journal of Physiology. Gastrointestinal and Liver Physiology. PMID 35638693 DOI: 10.1152/ajpgi.00066.2022  0.335
2020 Held P, Klassen BJ, Small CF, Brennan MB, Horn RV, Karnik NS, Pollack MH, Zalta AK. A Case Report of Cognitive Processing Therapy Delivered over a Single Week. Cognitive and Behavioral Practice. 27: 126-135. PMID 33041618 DOI: 10.1016/J.Cbpra.2019.07.006  0.369
2020 Held P, Zalta AK, Smith DL, Bagley JM, Steigerwald VL, Boley RA, Miller M, Brennan MB, Van Horn R, Pollack MH. Maintenance of treatment gains up to 12-months following a three-week cognitive processing therapy-based intensive PTSD treatment programme for veterans. European Journal of Psychotraumatology. 11: 1789324. PMID 33029327 DOI: 10.1080/20008198.2020.1789324  0.367
2020 Dowd SM, Zalta AK, Burgess HJ, Adkins EC, Valdespino-Hayden Z, Pollack MH. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World Journal of Psychiatry. 10: 21-28. PMID 32257848 DOI: 10.5498/Wjp.V10.I3.21  0.345
2020 Lofgreen AM, Tirone V, Carroll KK, Rufa AK, Smith DL, Bagley J, Zalta AK, Brennan MB, Van Horn R, Pollack MH, Held P. Improving outcomes for a 3-week intensive treatment program for posttraumatic stress disorder in survivors of military sexual trauma. Journal of Affective Disorders. 269: 134-140. PMID 32250866 DOI: 10.1016/J.Jad.2020.03.036  0.375
2020 Zalta AK, Pinkerton LM, Valdespino-Hayden Z, Smith DL, Burgess HJ, Held P, Boley RA, Karnik NS, Pollack MH. Examining Insomnia During Intensive Treatment for Veterans with Posttraumatic Stress Disorder: Does it Improve and Does it Predict Treatment Outcomes? Journal of Traumatic Stress. PMID 32216141 DOI: 10.1002/Jts.22505  0.378
2020 Tirone V, Smith D, Steigerwald VL, Bagley JM, Brennan M, Van Horn R, Pollack M, Held P. Examining the Impact of Sexual Revictimization in a Sample of Veterans Undergoing Intensive PTSD Treatment. Journal of Interpersonal Violence. 886260519897333. PMID 31898925 DOI: 10.1177/0886260519897333  0.363
2020 Huffman JC, Pollack MH, Stern TA. Panic Disorder and Chest Pain: Mechanisms, Morbidity, and Management. Primary Care Companion to the Journal of Clinical Psychiatry. 4: 54-62. PMID 15014745 DOI: 10.4088/Pcc.V04N0203  0.403
2019 Rosenfield D, Smits JAJ, Hofmann SG, Mataix-Cols D, de la Cruz LF, Andersson E, Rück C, Monzani B, Pérez-Vigil A, Frumento P, Davis M, de Kleine RA, Difede J, Dunlop BW, Farrell LJ, ... ... Pollack MH, et al. Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis. Journal of Anxiety Disorders. 68: 102149. PMID 31698111 DOI: 10.1016/J.Janxdis.2019.102149  0.323
2019 Hofmann SG, Papini S, Carpenter JK, Otto MW, Rosenfield D, Dutcher CD, Dowd S, Lewis M, Witcraft S, Pollack MH, Smits JAJ. Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder. Plos One. 14: e0223729. PMID 31622374 DOI: 10.1371/Journal.Pone.0223729  0.346
2019 Held P, Klassen BJ, Boley RA, Wiltsey Stirman S, Smith DL, Brennan MB, Van Horn R, Pollack MH, Karnik NS, Zalta AK. Feasibility of a 3-week intensive treatment program for service members and veterans with PTSD. Psychological Trauma : Theory, Research, Practice and Policy. PMID 31318250 DOI: 10.1037/Tra0000485  0.381
2019 Zalta AK, Bravo K, Valdespino-Hayden Z, Pollack MH, Burgess HJ. A placebo-controlled pilot study of a wearable morning bright light treatment for probable PTSD. Depression and Anxiety. PMID 30995350 DOI: 10.1002/Da.22897  0.41
2019 Held P, Bagley JM, Klassen BJ, Pollack MH. Intensively Delivered Cognitive-Behavioral Therapies: An Overview of a Promising Treatment Delivery Format for PTSD and Other Mental Health Disorders Psychiatric Annals. 49: 339-342. DOI: 10.3928/00485713-20190711-01  0.402
2018 Horwitz AG, Held P, Klassen BJ, Karnik NS, Pollack MH, Zalta AK. Posttraumatic Cognitions and Suicidal Ideation among Veterans receiving PTSD Treatment. Cognitive Therapy and Research. 42: 711-719. PMID 30505042 DOI: 10.1007/S10608-018-9925-6  0.327
2018 Zalta AK, Held P, Smith DL, Klassen BJ, Lofgreen AM, Normand PS, Brennan MB, Rydberg TS, Boley RA, Pollack MH, Karnik NS. Evaluating patterns and predictors of symptom change during a three-week intensive outpatient treatment for veterans with PTSD. Bmc Psychiatry. 18: 242. PMID 30053860 DOI: 10.1186/S12888-018-1816-6  0.389
2018 Carroll KK, Lofgreen AM, Weaver DC, Held P, Klassen BJ, Smith DL, Karnik NS, Pollack MH, Zalta AK. Negative posttraumatic cognitions among military sexual trauma survivors. Journal of Affective Disorders. 238: 88-93. PMID 29864715 DOI: 10.1016/J.Jad.2018.05.024  0.332
2017 Harvey MM, Rauch SAM, Zalta AK, Sornborger J, Pollack MH, Rothbaum BO, Laifer LM, Simon NM. Intensive Treatment Models to Address Posttraumatic Stress Among Post-9/11 Warriors: The Warrior Care Network. Focus (American Psychiatric Publishing). 15: 378-383. PMID 31975867 DOI: 10.1176/appi.focus.20170022  0.459
2017 Pollack MH, Simon NM, Rothbaum BO. Care of Veterans Through the Warrior Care Network. Focus (American Psychiatric Publishing). 15: 377. PMID 31975866 DOI: 10.1176/appi.focus.20170037  0.388
2017 Roque AD, Rosenfield D, Smits JAJ, Simon N, Otto MW, Marques L, Pollack MH, Hofmann SG, Meuret AE. Does d-cycloserine facilitate the effects of homework compliance on social anxiety symptom reduction? Journal of Anxiety Disorders. 53: 85-90. PMID 29227845 DOI: 10.1016/J.Janxdis.2017.11.004  0.613
2017 Held P, Klassen BJ, Zou DS, Schroedter BS, Karnik NS, Pollack MH, Zalta AK. Negative Posttrauma Cognitions Mediate the Association Between Morally Injurious Events and Trauma-Related Psychopathology in Treatment-Seeking Veterans. Journal of Traumatic Stress. PMID 29140560 DOI: 10.1002/Jts.22234  0.328
2017 Zalta AK, Bui E, Karnik NS, Held P, Laifer LM, Sager JC, Zou D, Rauch PK, Simon NM, Pollack MH, Ohye B. Examining the Relationship Between Parent and Child Psychopathology in Treatment-Seeking Veterans. Child Psychiatry and Human Development. PMID 28660407 DOI: 10.1007/S10578-017-0743-Y  0.522
2017 Hoge EA, Guidos BM, Mete M, Bui E, Pollack MH, Simon NM, Dutton MA. Effects of mindfulness meditation on occupational functioning and health care utilization in individuals with anxiety. Journal of Psychosomatic Research. 95: 7-11. PMID 28314552 DOI: 10.1016/J.Jpsychores.2017.01.011  0.622
2017 Hoge EA, Bui E, Palitz SA, Schwarz NR, Owens ME, Johnston JM, Pollack MH, Simon NM. The effect of mindfulness meditation training on biological acute stress responses in generalized anxiety disorder. Psychiatry Research. PMID 28131433 DOI: 10.1016/J.Psychres.2017.01.006  0.613
2017 Mataix-Cols D, Fernández de la Cruz L, Monzani B, Rosenfield D, Andersson E, Pérez-Vigil A, Frumento P, de Kleine RA, Difede J, Dunlop BW, Farrell LJ, Geller D, Gerardi M, Guastella AJ, Hofmann SG, ... ... Pollack MH, et al. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis. Jama Psychiatry. PMID 28122091 DOI: 10.1001/Jamapsychiatry.2016.3955  0.433
2016 Otto MW, Pollack MH, Dowd SM, Hofmann SG, Pearlson G, Szuhany KL, Gueorguieva R, Krystal JH, Simon NM, Tolin DF. RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER. Depression and Anxiety. PMID 27315514 DOI: 10.1002/Da.22531  0.594
2016 Zalta AK, Tirone V, Siedjak J, Boley RA, Vechiu C, Pollack MH, Hobfoll SE. A Pilot Study of Tailored Cognitive-Behavioral Resilience Training for Trauma Survivors With Subthreshold Distress. Journal of Traumatic Stress. PMID 27121865 DOI: 10.1002/Jts.22094  0.337
2016 Meuret AE, Chmielewski M, Steele AM, Rosenfield D, Petersen S, Smits JA, Simon NM, Otto MW, Marques L, Pollack MH, Hofmann SG. The desire to belong: Social identification as a predictor of treatment outcome in social anxiety disorder. Behaviour Research and Therapy. 81: 21-34. PMID 27070526 DOI: 10.1016/J.Brat.2016.03.008  0.569
2016 Pollack MH. Unmet needs in the treatment of anxiety disorders. Psychopharmacology Bulletin. 38: 31-7. PMID 15278016  0.447
2015 Otto MW, Kredlow MA, Smits JA, Hofmann SG, Tolin DF, de Kleine RA, van Minnen A, Evins AE, Pollack MH. Enhancement of Psychosocial Treatment With d-Cycloserine: Models, Moderators, and Future Directions. Biological Psychiatry. PMID 26520240 DOI: 10.1016/J.Biopsych.2015.09.007  0.387
2015 Mundy EA, Weber M, Rauch SL, Killgore WD, Simon NM, Pollack MH, Rosso IM. ADULT ANXIETY DISORDERS IN RELATION TO TRAIT ANXIETY AND PERCEIVED STRESS IN CHILDHOOD. Psychological Reports. 117: 473-489. PMID 26340052 DOI: 10.2466/02.10.Pr0.117C17Z6  0.617
2015 Whitfield-Gabrieli S, Ghosh SS, Nieto-Castanon A, Saygin Z, Doehrmann O, Chai XJ, Reynolds GO, Hofmann SG, Pollack MH, Gabrieli JD. Brain connectomics predict response to treatment in social anxiety disorder. Molecular Psychiatry. PMID 26260493 DOI: 10.1038/Mp.2015.109  0.413
2015 Hofmann SG, Carpenter JK, Otto MW, Rosenfield D, Smits JA, Pollack MH. Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale. Contemporary Clinical Trials. 43: 223-30. PMID 26111923 DOI: 10.1016/J.Cct.2015.06.015  0.463
2015 Manning J, Reynolds G, Saygin ZM, Hofmann SG, Pollack M, Gabrieli JD, Whitfield-Gabrieli S. Altered resting-state functional connectivity of the frontal-striatal reward system in social anxiety disorder. Plos One. 10: e0125286. PMID 25928647 DOI: 10.1371/Journal.Pone.0125286  0.344
2015 Webb AK, Vincent AL, Jin AB, Pollack MH. Physiological reactivity to nonideographic virtual reality stimuli in veterans with and without PTSD. Brain and Behavior. 5: e00304. PMID 25642387 DOI: 10.1002/Brb3.304  0.384
2015 Hofmann SG, Otto MW, Pollack MH, Smits JA. D-cycloserine augmentation of cognitive behavioral therapy for anxiety disorders: an update. Current Psychiatry Reports. 17: 532. PMID 25413638 DOI: 10.1007/S11920-014-0532-2  0.439
2014 Otto MW, Hearon BA, McHugh RK, Calkins AW, Pratt E, Murray HW, Safren SA, Pollack MH. A randomized, controlled trial of the efficacy of an interoceptive exposure-based CBT for treatment-refractory outpatients with opioid dependence. Journal of Psychoactive Drugs. 46: 402-11. PMID 25364993 DOI: 10.1080/02791072.2014.960110  0.331
2014 Otto MW, Moshier SJ, Kinner DG, Simon NM, Pollack MH, Orr SP. De novo fear conditioning across diagnostic groups in the affective disorders: evidence for learning impairments. Behavior Therapy. 45: 619-29. PMID 25022773 DOI: 10.1016/J.Beth.2013.12.012  0.65
2014 Pollack MH, Stein M, Simon N, Van Ameringen M. Response to Silberman. The American Journal of Psychiatry. 171: 795-6. PMID 24980175 DOI: 10.1176/Appi.Ajp.2014.14010048R  0.46
2014 Smoller JW, Gallagher PJ, Duncan LE, McGrath LM, Haddad SA, Holmes AJ, Wolf AB, Hilker S, Block SR, Weill S, Young S, Choi EY, Rosenbaum JF, Biederman J, Faraone SV, ... ... Pollack MH, et al. The human ortholog of acid-sensing ion channel gene ASIC1a is associated with panic disorder and amygdala structure and function. Biological Psychiatry. 76: 902-10. PMID 24529281 DOI: 10.1016/J.Biopsych.2013.12.018  0.543
2014 Pollack MH, Van Ameringen M, Simon NM, Worthington JW, Hoge EA, Keshaviah A, Stein MB. A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder. The American Journal of Psychiatry. 171: 44-53. PMID 24399428 DOI: 10.1176/Appi.Ajp.2013.12101353  0.67
2014 Stein MB, Keshaviah A, Haddad SA, Van Ameringen M, Simon NM, Pollack MH, Smoller JW. Influence of RGS2 on sertraline treatment for social anxiety disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1340-6. PMID 24154666 DOI: 10.1038/Npp.2013.301  0.604
2014 Killgore WD, Britton JC, Schwab ZJ, Price LM, Weiner MR, Gold AL, Rosso IM, Simon NM, Pollack MH, Rauch SL. Cortico-limbic responses to masked affective faces across ptsd, panic disorder, and specific phobia. Depression and Anxiety. 31: 150-9. PMID 23861215 DOI: 10.1002/Da.22156  0.649
2014 Pollack M, Doehrmann O, Ghosh S, Polli F, Reynolds G, Horn F, Keshavan A, Triantafyllou C, Saygin Z, Whitfield-Gabrieli S, Hofmann S, Gabrieli J. S.25.04 Neuroimaging predictors of treatment response in social phobia European Neuropsychopharmacology. 24: S142-S143. DOI: 10.1016/S0924-977X(14)70206-8  0.317
2013 Aderka IM, Pollack MH, Simon NM, Smits JA, Van Ameringen M, Stein MB, Hofmann SG. Development of a brief version of the Social Phobia Inventory using item response theory: the Mini-SPIN-R. Behavior Therapy. 44: 651-61. PMID 24094790 DOI: 10.1016/J.Beth.2013.04.011  0.541
2013 Anderson EC, Dryman MT, Worthington J, Hoge EA, Fischer LE, Pollack MH, Barrett LF, Simon NM. Smiles may go unseen in generalized social anxiety disorder: evidence from binocular rivalry for reduced visual consciousness of positive facial expressions. Journal of Anxiety Disorders. 27: 619-26. PMID 24064330 DOI: 10.1016/J.Janxdis.2013.07.004  0.574
2013 Zalta AK, Dowd S, Rosenfield D, Smits JA, Otto MW, Simon NM, Meuret AE, Marques L, Hofmann SG, Pollack MH. Sleep quality predicts treatment outcome in CBT for social anxiety disorder. Depression and Anxiety. 30: 1114-20. PMID 24038728 DOI: 10.1002/Da.22170  0.568
2013 Smits JA, Hofmann SG, Rosenfield D, DeBoer LB, Costa PT, Simon NM, O'Cleirigh C, Meuret AE, Marques L, Otto MW, Pollack MH. D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables. Journal of Consulting and Clinical Psychology. 81: 1100-12. PMID 23937345 DOI: 10.1037/A0034120  0.62
2013 Smits JA, Rosenfield D, Otto MW, Marques L, Davis ML, Meuret AE, Simon NM, Pollack MH, Hofmann SG. D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions. Journal of Psychiatric Research. 47: 1455-61. PMID 23870811 DOI: 10.1016/J.Jpsychires.2013.06.020  0.593
2013 Bui E, Orr SP, Jacoby RJ, Keshaviah A, Leblanc NJ, Milad MR, Pollack MH, Simon NM. Two weeks of pretreatment with escitalopram facilitates extinction learning in healthy individuals Human Psychopharmacology. 28: 447-456. PMID 23776033 DOI: 10.1002/Hup.2330  0.555
2013 Weber M, Killgore WD, Rosso IM, Britton JC, Schwab ZJ, Weiner MR, Simon NM, Pollack MH, Rauch SL. Voxel-based morphometric gray matter correlates of posttraumatic stress disorder. Journal of Anxiety Disorders. 27: 413-9. PMID 23746489 DOI: 10.1016/J.Janxdis.2013.04.004  0.59
2013 Hoge EA, Chen MM, Orr E, Metcalf CA, Fischer LE, Pollack MH, De Vivo I, Simon NM. Loving-Kindness Meditation practice associated with longer telomeres in women. Brain, Behavior, and Immunity. 32: 159-63. PMID 23602876 DOI: 10.1016/J.Bbi.2013.04.005  0.511
2013 Hofmann SG, Smits JA, Rosenfield D, Simon N, Otto MW, Meuret AE, Marques L, Fang A, Tart C, Pollack MH. D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder. The American Journal of Psychiatry. 170: 751-8. PMID 23599046 DOI: 10.1176/Appi.Ajp.2013.12070974  0.641
2013 Hoge EA, Bui E, Marques L, Metcalf CA, Morris LK, Robinaugh DJ, Worthington JJ, Pollack MH, Simon NM. Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity. The Journal of Clinical Psychiatry. 74: 786-92. PMID 23541163 DOI: 10.4088/Jcp.12M08083  0.675
2013 McHugh RK, Murray HW, Hearon BA, Pratt EM, Pollack MH, Safren SA, Otto MW. Predictors of dropout from psychosocial treatment in opioid-dependent outpatients. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 22: 18-22. PMID 23398222 DOI: 10.1111/J.1521-0391.2013.00317.X  0.305
2013 Smits JA, Rosenfield D, Otto MW, Powers MB, Hofmann SG, Telch MJ, Pollack MH, Tart CD. D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia. Biological Psychiatry. 73: 1054-8. PMID 23332511 DOI: 10.1016/J.Biopsych.2012.12.009  0.343
2013 Tart CD, Handelsman PR, Deboer LB, Rosenfield D, Pollack MH, Hofmann SG, Powers MB, Otto MW, Smits JA. Augmentation of exposure therapy with post-session administration of D-cycloserine. Journal of Psychiatric Research. 47: 168-74. PMID 23098672 DOI: 10.1016/J.Jpsychires.2012.09.024  0.354
2013 Doehrmann O, Ghosh SS, Polli FE, Reynolds GO, Horn F, Keshavan A, Triantafyllou C, Saygin ZM, Whitfield-Gabrieli S, Hofmann SG, Pollack M, Gabrieli JD. Predicting treatment response in social anxiety disorder from functional magnetic resonance imaging. Jama Psychiatry. 70: 87-97. PMID 22945462 DOI: 10.1001/2013.Jamapsychiatry.5  0.461
2012 Hoge EA, Lawson EA, Metcalf CA, Keshaviah A, Zak PJ, Pollack MH, Simon NM. Plasma oxytocin immunoreactive products and response to trust in patients with social anxiety disorder. Depression and Anxiety. 29: 924-30. PMID 22807189 DOI: 10.1002/Da.21973  0.593
2012 Marques L, Porter E, Keshaviah A, Pollack MH, Van Ameringen M, Stein MB, Simon NM. Avoidant personality disorder in individuals with generalized social anxiety disorder: what does it add? Journal of Anxiety Disorders. 26: 665-72. PMID 22705954 DOI: 10.1016/J.Janxdis.2012.05.004  0.655
2012 Sung SC, Porter E, Robinaugh DJ, Marks EH, Marques LM, Otto MW, Pollack MH, Simon NM. Mood regulation and quality of life in social anxiety disorder: an examination of generalized expectancies for negative mood regulation. Journal of Anxiety Disorders. 26: 435-41. PMID 22343166 DOI: 10.1016/J.Janxdis.2012.01.004  0.617
2012 Keough ME, Porter E, Kredlow MA, Worthington JJ, Hoge EA, Pollack MH, Shear MK, Simon NM. Anchoring the Panic Disorder Severity Scale. Assessment. 19: 257-9. PMID 22327206 DOI: 10.1177/1073191112436668  0.624
2012 Fava M, Mischoulon D, Iosifescu D, Witte J, Pencina M, Flynn M, Harper L, Levy M, Rickels K, Pollack M. A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study). Psychotherapy and Psychosomatics. 81: 87-97. PMID 22286203 DOI: 10.1159/000332050  0.306
2012 Hoge EA, Worthington JJ, Nagurney JT, Chang Y, Kay EB, Feterowski CM, Katzman AR, Goetz JM, Rosasco ML, Lasko NB, Zusman RM, Pollack MH, Orr SP, Pitman RK. Effect of acute posttrauma propranolol on PTSD outcome and physiological responses during script-driven imagery. Cns Neuroscience & Therapeutics. 18: 21-7. PMID 22070357 DOI: 10.1111/J.1755-5949.2010.00227.X  0.364
2012 Mischoulon D, Witte J, Levy M, Papakostas GI, Pet LR, Hsieh WH, Pencina MJ, Ward S, Pollack MH, Fava M. Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial. The Journal of Clinical Psychiatry. 73: 353-7. PMID 21939613 DOI: 10.4088/Jcp.10M06541  0.333
2012 Pollack MH, Marzol PC. Pharmacotherapeutic options in the treatment of comorbid depression and anxiety. Cns Spectrums. 5: 23-30. PMID 17545962 DOI: 10.1017/S1092852900007781  0.514
2011 Robinaugh DJ, Marques L, Traeger LN, Marks EH, Sung SC, Gayle Beck J, Pollack MH, Simon NM. Understanding the relationship of perceived social support to post-trauma cognitions and posttraumatic stress disorder. Journal of Anxiety Disorders. 25: 1072-8. PMID 21820854 DOI: 10.1016/J.Janxdis.2011.07.004  0.572
2011 Pollack MH, Hoge EA, Worthington JJ, Moshier SJ, Wechsler RS, Brandes M, Simon NM. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial. The Journal of Clinical Psychiatry. 72: 892-7. PMID 21367352 DOI: 10.4088/Jcp.09M05607Gry  0.617
2011 Hinton DE, Hofmann SG, Rivera E, Otto MW, Pollack MH. Culturally adapted CBT (CA-CBT) for Latino women with treatment-resistant PTSD: a pilot study comparing CA-CBT to applied muscle relaxation. Behaviour Research and Therapy. 49: 275-80. PMID 21333272 DOI: 10.1016/J.Brat.2011.01.005  0.338
2011 Hoge EA, Marques L, Wechsler RS, Lasky AK, Delong HR, Jacoby RJ, Worthington JJ, Pollack MH, Simon NM. The role of anxiety sensitivity in sleep disturbance in panic disorder. Journal of Anxiety Disorders. 25: 536-8. PMID 21277737 DOI: 10.1016/J.Janxdis.2010.12.008  0.524
2010 Applebaum AJ, Bullis JR, Traeger LN, O'cleirigh C, Otto MW, Pollack MH, Safren SA. Rates of mood and anxiety disorders and contributors to continued heroin use in methadone maintenance patients: A comparison by HIV status. Neurobehavioral Hiv Medicine. 2010: 49-57. PMID 24062619 DOI: 10.2147/NBHIV.S12371  0.364
2010 Simon NM, Worthington JJ, Moshier SJ, Marks EH, Hoge EA, Brandes M, Delong H, Pollack MH. Duloxetine for the treatment of generalized social anxiety disorder: a preliminary randomized trial of increased dose to optimize response. Cns Spectrums. 15: 367-73. PMID 20625362 DOI: 10.1017/S1092852900000365  0.649
2010 Otto MW, McHugh RK, Simon NM, Farach FJ, Worthington JJ, Pollack MH. Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation. Behaviour Research and Therapy. 48: 720-7. PMID 20546699 DOI: 10.1016/J.Brat.2010.04.002  0.683
2010 Hinton DE, Pich V, Marques L, Nickerson A, Pollack MH. Khyâl attacks: a key idiom of distress among traumatized cambodia refugees. Culture, Medicine and Psychiatry. 34: 244-78. PMID 20407813 DOI: 10.1007/S11013-010-9174-Y  0.365
2010 Stein MB, Ravindran LN, Simon NM, Liebowitz MR, Khan A, Brawman-Mintzer O, Lydiard RB, Pollack MH. Levetiracetam in generalized social anxiety disorder: a double-blind, randomized controlled trial. The Journal of Clinical Psychiatry. 71: 627-31. PMID 20021997 DOI: 10.4088/Jcp.08M04949Gre  0.657
2010 Otto MW, Tolin DF, Simon NM, Pearlson GD, Basden S, Meunier SA, Hofmann SG, Eisenmenger K, Krystal JH, Pollack MH. Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biological Psychiatry. 67: 365-70. PMID 19811776 DOI: 10.1016/J.Biopsych.2009.07.036  0.614
2010 Chandler GM, Iosifescu DV, Pollack MH, Targum SD, Fava M. RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ). Cns Neuroscience & Therapeutics. 16: 322-5. PMID 19769599 DOI: 10.1111/J.1755-5949.2009.00102.X  0.33
2010 Hinton DE, Hofmann SG, Orr SP, Pitman RK, Pollack MH, Pole N. A psychobiocultural model of orthostatic panic among cambodian refugees: Flashbacks, catastrophic cognitions, and reduced orthostatic blood-pressure response Psychological Trauma: Theory, Research, Practice, and Policy. 2: 63-70. DOI: 10.1037/A0018978  0.368
2010 Davidson J, Pollack M, Brewster C. P7– Considerations for development of Generalized Anxiety Disorder Guidelines (GAD) in the US Otolaryngology–Head and Neck Surgery. 143: 81-82. DOI: 10.1016/J.Otohns.2010.04.031  0.508
2009 Simon NM, Otto MW, Worthington JJ, Hoge EA, Thompson EH, Lebeau RT, Moshier SJ, Zalta AK, Pollack MH. Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial. The Journal of Clinical Psychiatry. 70: 1563-70. PMID 19814948 DOI: 10.4088/Jcp.08M04485Blu  0.602
2009 Simon NM, Herlands NN, Marks EH, Mancini C, Letamendi A, Li Z, Pollack MH, Van Ameringen M, Stein MB. Childhood maltreatment linked to greater symptom severity and poorer quality of life and function in social anxiety disorder. Depression and Anxiety. 26: 1027-32. PMID 19750554 DOI: 10.1002/Da.20604  0.643
2009 Hinton DE, Rasmussen A, Nou L, Pollack MH, Good MJ. Anger, PTSD, and the nuclear family: a study of Cambodian refugees. Social Science & Medicine (1982). 69: 1387-94. PMID 19748169 DOI: 10.1016/J.Socscimed.2009.08.018  0.307
2009 Hinton DE, Park L, Hsia C, Hofmann S, Pollack MH. Anxiety disorder presentations in Asian populations: a review. Cns Neuroscience & Therapeutics. 15: 295-303. PMID 19691549 DOI: 10.1111/J.1755-5949.2009.00095.X  0.481
2009 Hinton DE, Lewis-Fernández R, Pollack MH. A model of the generation of ataque de nervios: the role of fear of negative affect and fear of arousal symptoms. Cns Neuroscience & Therapeutics. 15: 264-75. PMID 19691546 DOI: 10.1111/J.1755-5949.2009.00101.X  0.355
2009 Hinton DE, Hofmann SG, Pollack MH, Otto MW. Mechanisms of efficacy of CBT for Cambodian refugees with PTSD: improvement in emotion regulation and orthostatic blood pressure response. Cns Neuroscience & Therapeutics. 15: 255-63. PMID 19691545 DOI: 10.1111/J.1755-5949.2009.00100.X  0.391
2009 Hinton DE, Pollack MH. Introduction to the special issue: anxiety disorders in cross-cultural perspective. Cns Neuroscience & Therapeutics. 15: 207-9. PMID 19691539 DOI: 10.1111/J.1755-5949.2009.00097.X  0.474
2009 Marques L, Kaufman RE, LeBeau RT, Moshier SJ, Otto MW, Pollack MH, Simon NM. A comparison of emotional approach coping (EAC) between individuals with anxiety disorders and nonanxious controls. Cns Neuroscience & Therapeutics. 15: 100-6. PMID 19492991 DOI: 10.1111/J.1755-5949.2009.00080.X  0.617
2009 Pollack MH. Refractory generalized anxiety disorder Journal of Clinical Psychiatry. 70: 32-38. PMID 19371505 DOI: 10.4088/Jcp.S.7002.06  0.533
2009 Hinton DE, Hinton AL, Pich V, Loeum JR, Pollack MH. Nightmares among Cambodian refugees: the breaching of concentric ontological security. Culture, Medicine and Psychiatry. 33: 219-65. PMID 19333741 DOI: 10.1007/S11013-009-9131-9  0.359
2009 Hoge EA, Brandstetter K, Moshier S, Pollack MH, Wong KK, Simon NM. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depression and Anxiety. 26: 447-55. PMID 19319993 DOI: 10.1002/Da.20564  0.653
2009 Simon NM, Kaufman RE, Hoge EA, Worthington JJ, Herlands NN, Owens ME, Pollack MH. Open-label support for duloxetine for the treatment of panic disorder. Cns Neuroscience & Therapeutics. 15: 19-23. PMID 19228176 DOI: 10.1111/J.1755-5949.2008.00076.X  0.693
2009 Kaufman RE, Ostacher MJ, Marks EH, Simon NM, Sachs GS, Jensen JE, Renshaw PF, Pollack MH. Brain GABA levels in patients with bipolar disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 33: 427-34. PMID 19171176 DOI: 10.1016/J.Pnpbp.2008.12.025  0.572
2009 Evans KC, Simon NM, Dougherty DD, Hoge EA, Worthington JJ, Chow C, Kaufman RE, Gold AL, Fischman AJ, Pollack MH, Rauch SL. A PET study of tiagabine treatment implicates ventral medial prefrontal cortex in generalized social anxiety disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 390-8. PMID 18536708 DOI: 10.1038/Npp.2008.69  0.588
2008 George MS, Ward HE, Ninan PT, Pollack M, Nahas Z, Anderson B, Kose S, Howland RH, Goodman WK, Ballenger JC. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimulation. 1: 112-21. PMID 20633378 DOI: 10.1016/J.Brs.2008.02.001  0.502
2008 Hoge EA, Pollack MH, Kaufman RE, Zak PJ, Simon NM. Oxytocin levels in social anxiety disorder. Cns Neuroscience & Therapeutics. 14: 165-70. PMID 18801109 DOI: 10.1111/J.1755-5949.2008.00051.X  0.605
2008 Hoge EA, Worthington JJ, Kaufman RE, Delong HR, Pollack MH, Simon NM. Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder. Cns Spectrums. 13: 522-7. PMID 18567977 DOI: 10.1017/S109285290001676X  0.686
2008 Hinton DE, Hinton SD, Loeum RJ, Pich V, Pollack MH. The 'multiplex model' of somatic symptoms: application to tinnitus among traumatized Cambodian refugees. Transcultural Psychiatry. 45: 287-317. PMID 18562496 DOI: 10.1177/1363461508089768  0.316
2008 Targum SD, Pollack MH, Fava M. Redefining affective disorders: relevance for drug development. Cns Neuroscience & Therapeutics. 14: 2-9. PMID 18482094 DOI: 10.1111/J.1527-3458.2008.00038.X  0.327
2008 Pollack MH, Tiller J, Xie F, Trivedi MH. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies. Journal of Clinical Psychopharmacology. 28: 308-16. PMID 18480688 DOI: 10.1097/Jcp.0B013E318172B45F  0.421
2008 Davidson J, Allgulander C, Pollack MH, Hartford J, Erickson JS, Russell JM, Perahia D, Wohlreich MM, Carlson J, Raskin J. Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies. Human Psychopharmacology. 23: 519-26. PMID 18478624 DOI: 10.1002/Hup.949  0.443
2008 Hinton DE, Hofmann SG, Pitman RK, Pollack MH, Barlow DH. The panic attack-posttraumatic stress disorder model: applicability to orthostatic panic among Cambodian refugees. Cognitive Behaviour Therapy. 37: 101-16. PMID 18470741 DOI: 10.1080/16506070801969062  0.441
2008 Pollack M, Kinrys G, Krystal A, McCall WV, Roth T, Schaefer K, Rubens R, Roach J, Huang H, Krishnan R. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Archives of General Psychiatry. 65: 551-62. PMID 18458207 DOI: 10.1001/Archpsyc.65.5.551  0.531
2008 Pollack MH, Kornstein SG, Spann ME, Crits-Christoph P, Raskin J, Russell JM. Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint. Journal of Psychiatric Research. 42: 1176-84. PMID 18348888 DOI: 10.1016/J.Jpsychires.2008.02.002  0.419
2008 Simon NM, Connor KM, Lang AJ, Rauch S, Krulewicz S, LeBeau RT, Davidson JR, Stein MB, Otto MW, Foa EB, Pollack MH. Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy. The Journal of Clinical Psychiatry. 69: 400-5. PMID 18348595 DOI: 10.4088/Jcp.V69N0309  0.595
2008 Simon NM, Connor KM, LeBeau RT, Hoge EA, Worthington JJ, Zhang W, Davidson JR, Pollack MH. Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings. Psychopharmacology. 197: 675-81. PMID 18246327 DOI: 10.1007/S00213-008-1087-X  0.687
2008 Pollack MH, Endicott J, Liebowitz M, Russell J, Detke M, Spann M, Ball S, Swindle R. Examining quality of life in patients with generalized anxiety disorder: Clinical relevance and response to duloxetine treatment Journal of Psychiatric Research. 42: 1042-1049. PMID 18221755 DOI: 10.1016/J.Jpsychires.2007.11.006  0.475
2008 Pollack MH, Jensen JE, Simon NM, Kaufman RE, Renshaw PF. High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 32: 739-43. PMID 18206286 DOI: 10.1016/J.Pnpbp.2007.11.023  0.636
2008 Taylor CT, Hirshfeld-Becker DR, Ostacher MJ, Chow CW, LeBeau RT, Pollack MH, Nierenberg AA, Simon NM. Anxiety is associated with impulsivity in bipolar disorder. Journal of Anxiety Disorders. 22: 868-76. PMID 17936573 DOI: 10.1016/J.Janxdis.2007.09.001  0.677
2008 Simon NM, McNamara K, Chow CW, Maser RS, Papakostas GI, Pollack MH, Nierenberg AA, Fava M, Wong KK. A detailed examination of cytokine abnormalities in Major Depressive Disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 18: 230-3. PMID 17681762 DOI: 10.1016/J.Euroneuro.2007.06.004  0.564
2008 Hinton DE, Chong R, Pollack MH, Barlow DH, McNally RJ. Ataque de nervios: relationship to anxiety sensitivity and dissociation predisposition. Depression and Anxiety. 25: 489-95. PMID 17570492 DOI: 10.1002/Da.20309  0.359
2008 Pollack MH, Otto MW, Roy-Byrne PP, Coplan JD, Rothbaum BO, Simon NM, Gorman JM. Novel treatment approaches for refractory anxiety disorders. Depression and Anxiety. 25: 467-76. PMID 17437259 DOI: 10.1002/Da.20329  0.678
2008 Olatunji BO, Feldman G, Smits JA, Christian KM, Zalta AK, Pollack MH, Simon NM. Examination of the decline in symptoms of anxiety and depression in generalized anxiety disorder: impact of anxiety sensitivity on response to pharmacotherapy. Depression and Anxiety. 25: 167-71. PMID 17335002 DOI: 10.1002/Da.20283  0.556
2008 Delong H, Pollack MH. Update on the Assessment, Diagnosis, and Treatment of Individuals with Social Anxiety Disorder Focus. 6: 431-437. DOI: 10.1176/FOC.6.4.FOC431  0.393
2008 Rapaport MH, Wolkow R, Rubin A, Hackett E, Pollack M, Ota KY. Sertraline treatment of panic disorder: results of a long-term study: Long-term sertraline treatment Acta Psychiatrica Scandinavica. 104: 289-298. DOI: 10.1111/J.1600-0447.2001.00263.X  0.366
2008 Fava M, Pollack M, Montgomery S, Wessel T, Amato D, Krystal A, Hayduk R, McCall W. Evaluation of the HAM-D17 following eszopiclone treatment in patients with insomnia co-morbid with major depressive disorder or generalized anxiety disorder European Psychiatry. 23: S360. DOI: 10.1016/J.Eurpsy.2008.01.1247  0.516
2008 Soroudi N, Perez GK, Gonzalez JS, Greer JA, Pollack MH, Otto MW, Safren SA. CBT for Medication Adherence and Depression (CBT-AD) in HIV-Infected Patients Receiving Methadone Maintenance Therapy Cognitive and Behavioral Practice. 15: 93-106. DOI: 10.1016/J.Cbpra.2006.11.004  0.302
2007 Maytal G, Zalta AK, Thompson E, Chow CW, Perlman C, Ostacher MJ, Pollack MH, Shear K, Simon NM. Complicated grief and impaired sleep in patients with bipolar disorder. Bipolar Disorders. 9: 913-7. PMID 18076543 DOI: 10.1111/J.1399-5618.2007.00446.X  0.587
2007 Simon NM, Thompson EH, Pollack MH, Shear MK. Complicated grief: a case series using escitalopram. The American Journal of Psychiatry. 164: 1760-1. PMID 17974946 DOI: 10.1176/Appi.Ajp.2007.07050800  0.446
2007 Smoller JW, Pollack MH, Wassertheil-Smoller S, Jackson RD, Oberman A, Wong ND, Sheps D. Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study. Archives of General Psychiatry. 64: 1153-60. PMID 17909127 DOI: 10.1001/Archpsyc.64.10.1153  0.319
2007 Kinrys G, Worthington JJ, Wygant L, Nery F, Reese H, Pollack MH. Levetiracetam as adjunctive therapy for refractory anxiety disorders. The Journal of Clinical Psychiatry. 68: 1010-3. PMID 17685735 DOI: 10.4088/Jcp.V68N0705  0.542
2007 Pollack M, Mangano R, Entsuah R, Tzanis E, Simon NM, Zhang Y. A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder. Psychopharmacology. 194: 233-42. PMID 17589833 DOI: 10.1007/S00213-007-0821-0  0.619
2007 Otto MW, O' Cleirigh CM, Pollack MH. Attending to emotional cues for drug abuse: bridging the gap between clinic and home behaviors. Science & Practice Perspectives. 3: 48-56. PMID 17514074 DOI: 10.1151/Spp073248  0.34
2007 Hinton DE, Nguyen L, Pollack MH. Orthostatic panic as a key Vietnamese reaction to traumatic events: the case of September 11, 2001. Medical Anthropology Quarterly. 21: 81-107. PMID 17405699 DOI: 10.1525/Maq.2007.21.1.81  0.322
2007 Otto MW, Henin A, Hirshfeld-Becker DR, Pollack MH, Biederman J, Rosenbaum JF. Posttraumatic stress disorder symptoms following media exposure to tragic events: impact of 9/11 on children at risk for anxiety disorders. Journal of Anxiety Disorders. 21: 888-902. PMID 17276653 DOI: 10.1016/J.Janxdis.2006.10.008  0.342
2007 Davidson JR, Brady K, Mellman TA, Stein MB, Pollack MH. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. Journal of Clinical Psychopharmacology. 27: 85-8. PMID 17224720 DOI: 10.1097/Jcp.0B013E31802E5115  0.399
2007 Otto MW, Leyro TM, Christian K, Deveney CM, Reese H, Pollack MH, Orr SP. Prediction of "fear" acquisition in healthy control participants in a de novo fear-conditioning paradigm. Behavior Modification. 31: 32-51. PMID 17179530 DOI: 10.1177/0145445506295054  0.481
2007 Simon NM, Zalta AK, Otto MW, Ostacher MJ, Fischmann D, Chow CW, Thompson EH, Stevens JC, Demopulos CM, Nierenberg AA, Pollack MH. The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorder. Journal of Psychiatric Research. 41: 255-64. PMID 17052730 DOI: 10.1016/J.Jpsychires.2006.08.004  0.643
2007 Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder. Depression and Anxiety. 24: 1-14. PMID 16894619 DOI: 10.1002/da.20218  0.617
2007 Simon NM, Pollack MH, Ostacher MJ, Zalta AK, Chow CW, Fischmann D, Demopulos CM, Nierenberg AA, Otto MW. Understanding the link between anxiety symptoms and suicidal ideation and behaviors in outpatients with bipolar disorder. Journal of Affective Disorders. 97: 91-9. PMID 16820212 DOI: 10.1016/J.Jad.2006.05.027  0.643
2007 Hinton DE, Chhean D, Fama JM, Pollack MH, McNally RJ. Gastrointestinal-focused panic attacks among Cambodian refugees: associated psychopathology, flashbacks, and catastrophic cognitions. Journal of Anxiety Disorders. 21: 42-58. PMID 16650726 DOI: 10.1016/J.Janxdis.2006.03.009  0.39
2007 Dunner DL, Blier P, Keller MB, Pollack MH, Thase ME, Zajecka JM. Preventing recurrent depression: Long-term treatment for major depressive disorder Primary Care Companion to the Journal of Clinical Psychiatry. 9: 214-223. DOI: 10.4088/Jcp.0307E06  0.408
2007 Pollack M, Stein D, Mangano R, Musgnung J, Entsuah R, Simon N. Predictors of clinical outcome in panic disorder: Analysis of venlafaxine XR short-term treatment studies European Psychiatry. 22: S240. DOI: 10.1016/J.Eurpsy.2007.01.802  0.614
2007 Montgomery S, Kinrys G, Krystal A, McCall W, Roth T, Rubens R, Schaefer K, Roach J, Huang H, Krishnan R, Pollack M. Evaluation of eszopiclone and escitalopram oxalate co-therapy in patients with generalized anxiety disorder and insomnia European Psychiatry. 22: S238-S239. DOI: 10.1016/J.Eurpsy.2007.01.798  0.487
2007 Pollack M, Mangano R, Entsuah R, Tzanis E, Simon NM, Zhang Y. A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder Psychopharmacology. 196: 339-339. DOI: 10.1007/s00213-007-1011-9  0.337
2006 Hinton DE, Pich V, Chhean D, Safren SA, Pollack MH. Somatic-focused therapy for traumatized refugees: Treating posttraumatic stress disorder and comorbid neck-focused panic attacks among cambodian refugees. Psychotherapy (Chicago, Ill.). 43: 491-505. PMID 22122139 DOI: 10.1037/0033-3204.43.4.491  0.47
2006 Hofmann SG, Pollack MH, Otto MW. Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine. Cns Drug Reviews. 12: 208-17. PMID 17227287 DOI: 10.1111/J.1527-3458.2006.00208.X  0.501
2006 Hoge EA, Tamrakar SM, Christian KM, Mahara N, Nepal MK, Pollack MH, Simon NM. Cross-cultural differences in somatic presentation in patients with generalized anxiety disorder. The Journal of Nervous and Mental Disease. 194: 962-6. PMID 17164637 DOI: 10.1097/01.Nmd.0000243813.59385.75  0.631
2006 Simon NM, Weiss AM, Kradin R, Evans KC, Reese HE, Otto MW, Oppenheimer JE, Smoller JW, Zalta A, Worthington JJ, Pollack MH. The relationship of anxiety disorders, anxiety sensitivity and pulmonary dysfunction with dyspnea-related distress and avoidance. The Journal of Nervous and Mental Disease. 194: 951-7. PMID 17164635 DOI: 10.1097/01.Nmd.0000249062.25829.53  0.637
2006 Simon NM, Zalta AK, Worthington JJ, Hoge EA, Christian KM, Stevens JC, Pollack MH. Preliminary support for gender differences in response to fluoxetine for generalized anxiety disorder. Depression and Anxiety. 23: 373-6. PMID 17068858 DOI: 10.1002/Da.20184  0.593
2006 Otto MW, Simon NM, Wisniewski SR, Miklowitz DJ, Kogan JN, Reilly-Harrington NA, Frank E, Nierenberg AA, Marangell LB, Sagduyu K, Weiss RD, Miyahara S, Thas ME, Sachs GS, Pollack MH, et al. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. The British Journal of Psychiatry : the Journal of Mental Science. 189: 20-5. PMID 16816301 DOI: 10.1192/Bjp.Bp.104.007773  0.689
2006 Hinton DE, Chhean D, Pich V, Pollack MH, Orr SP, Pitman RK. Assessment of posttraumatic stress disorder in Cambodian refugees using the Clinician-Administered PTSD Scale: psychometric properties and symptom severity. Journal of Traumatic Stress. 19: 405-9. PMID 16788999 DOI: 10.1002/Jts.20115  0.413
2006 Biederman J, Petty C, Faraone SV, Henin A, Hirshfeld-Becker D, Pollack MH, de Figueiredo S, Feeley R, Rosenbaum JF. Effects of parental anxiety disorders in children at high risk for panic disorder: a controlled study. Journal of Affective Disorders. 94: 191-7. PMID 16753222 DOI: 10.1016/J.Jad.2006.04.012  0.483
2006 Pollack MH, Simon NM, Fagiolini A, Pitman R, McNally RJ, Nierenberg AA, Miyahara S, Sachs GS, Perlman C, Ghaemi SN, Thase ME, Otto MW. Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorder. The Journal of Clinical Psychiatry. 67: 394-9. PMID 16649825 DOI: 10.4088/Jcp.V67N0309  0.642
2006 Simon NM, Hoge EA, Fischmann D, Worthington JJ, Christian KM, Kinrys G, Pollack MH. An open-label trial of risperidone augmentation for refractory anxiety disorders. The Journal of Clinical Psychiatry. 67: 381-5. PMID 16649823 DOI: 10.4088/Jcp.V67N0307  0.694
2006 Simon NM, Smoller JW, McNamara KL, Maser RS, Zalta AK, Pollack MH, Nierenberg AA, Fava M, Wong KK. Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biological Psychiatry. 60: 432-5. PMID 16581033 DOI: 10.1016/J.Biopsych.2006.02.004  0.567
2006 Hinton DE, Pich V, Safren SA, Pollack MH, McNally RJ. Anxiety sensitivity among Cambodian refugees with panic disorder: A factor analytic investigation. Journal of Anxiety Disorders. 20: 281-95. PMID 16564433 DOI: 10.1016/J.Janxdis.2005.02.006  0.389
2006 Hofmann SG, Meuret AE, Smits JA, Simon NM, Pollack MH, Eisenmenger K, Shiekh M, Otto MW. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Archives of General Psychiatry. 63: 298-304. PMID 16520435 DOI: 10.1001/Archpsyc.63.3.298  0.626
2006 Evans KC, Dougherty DD, Pollack MH, Rauch SL. Using neuroimaging to predict treatment response in mood and anxiety disorders. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 18: 33-42. PMID 16517451 DOI: 10.1080/10401230500464661  0.464
2006 Hinton DE, Chhean D, Pich V, Um K, Fama JM, Pollack MH. Neck-focused panic attacks among Cambodian refugees; a logistic and linear regression analysis. Journal of Anxiety Disorders. 20: 119-38. PMID 16464700 DOI: 10.1016/J.Janxdis.2005.02.001  0.31
2006 Pollack MH, Simon NM, Zalta AK, Worthington JJ, Hoge EA, Mick E, Kinrys G, Oppenheimer J. Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study. Biological Psychiatry. 59: 211-5. PMID 16139813 DOI: 10.1016/J.Biopsych.2005.07.005  0.666
2006 Otto MW, Simon NM, Powers M, Hinton D, Zalta AK, Pollack MH. Rates of isolated sleep paralysis in outpatients with anxiety disorders. Journal of Anxiety Disorders. 20: 687-93. PMID 16099138 DOI: 10.1016/J.Janxdis.2005.07.002  0.679
2006 Pollack M, Stein D, Mangano R, Entsuah R, Simon N. P.4.c.003 Predictors of clinical outcome in panic disorder: a pooled analysis of venlafaxine extended release short-term treatment studies European Neuropsychopharmacology. 16: S465-S466. DOI: 10.1016/S0924-977X(06)70614-9  0.589
2006 Hinton DE, Safren SA, Pollack MH, Tran M. Cognitive-Behavior Therapy for Vietnamese Refugees With PTSD and Comorbid Panic Attacks Cognitive and Behavioral Practice. 13: 271-281. DOI: 10.1016/J.Cbpra.2006.04.008  0.4
2005 Pollack MH, Roy-Byrne PP, Van Ameringen M, Snyder H, Brown C, Ondrasik J, Rickels K. The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study. The Journal of Clinical Psychiatry. 66: 1401-8. PMID 16420077 DOI: 10.4088/Jcp.V66N1109  0.408
2005 Hinton DE, Chhean D, Pich V, Safren SA, Hofmann SG, Pollack MH. A randomized controlled trial of cognitive-behavior therapy for Cambodian refugees with treatment-resistant PTSD and panic attacks: a cross-over design. Journal of Traumatic Stress. 18: 617-29. PMID 16382423 DOI: 10.1002/Jts.20070  0.42
2005 Martinez JM, Marangell LB, Simon NM, Miyahara S, Wisniewski SR, Harrington J, Pollack MH, Sachs GS, Thase ME. Baseline predictors of serious adverse events at one year among patients with bipolar disorder in STEP-BD. Psychiatric Services (Washington, D.C.). 56: 1541-8. PMID 16339616 DOI: 10.1176/Appi.Ps.56.12.1541  0.634
2005 Pollack MH. Comorbid anxiety and depression Journal of Clinical Psychiatry. 66: 22-29. PMID 16336033  0.386
2005 Hinton DE, Pich V, Safren SA, Pollack MH, McNally RJ. Anxiety sensitivity in traumatized Cambodian refugees: a discriminant function and factor analytic investigation. Behaviour Research and Therapy. 43: 1631-43. PMID 16239155 DOI: 10.1016/J.Brat.2005.01.001  0.453
2005 Biederman J, Petty C, Faraone SV, Hirshfeld-Becker DR, Henin A, Rauf A, Scott M, Pollack M, Rosenbaum JF. Childhood antecedents to panic disorder in referred and nonreferred adults. Journal of Child and Adolescent Psychopharmacology. 15: 549-61. PMID 16190787 DOI: 10.1089/Cap.2005.15.549  0.495
2005 Simon NM, Pollack MH, Fischmann D, Perlman CA, Muriel AC, Moore CW, Nierenberg AA, Shear MK. Complicated grief and its correlates in patients with bipolar disorder. The Journal of Clinical Psychiatry. 66: 1105-10. PMID 16187766 DOI: 10.4088/Jcp.V66N0903  0.628
2005 Rickels K, Pollack MH, Feltner DE, Lydiard RB, Zimbroff DL, Bielski RJ, Tobias K, Brock JD, Zornberg GL, Pande AC. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Archives of General Psychiatry. 62: 1022-30. PMID 16143734 DOI: 10.1001/Archpsyc.62.9.1022  0.338
2005 Hinton DE, Pich V, Chhean D, Pollack MH, McNally RJ. Sleep paralysis among Cambodian refugees: association with PTSD diagnosis and severity. Depression and Anxiety. 22: 47-51. PMID 16094659 DOI: 10.1002/Da.20084  0.342
2005 Simon NM, Parker SW, Wernick-Robinson M, Oppenheimer JE, Hoge EA, Worthington JJ, Korbly NB, Pollack MH. Fluoxetine for vestibular dysfunction and anxiety: a prospective pilot study. Psychosomatics. 46: 334-9. PMID 16000676 DOI: 10.1176/Appi.Psy.46.4.334  0.652
2005 Weiss RD, Ostacher MJ, Otto MW, Calabrese JR, Fossey M, Wisniewski SR, Bowden CL, Nierenberg AA, Pollack MH, Salloum IM, Simon NM, Thase ME, Sachs GS. Does recovery from substance use disorder matter in patients with bipolar disorder? The Journal of Clinical Psychiatry. 66: 730-5; quiz 808-9. PMID 15960566 DOI: 10.4088/Jcp.V66N0609  0.654
2005 Nierenberg AA, Miyahara S, Spencer T, Wisniewski SR, Otto MW, Simon N, Pollack MH, Ostacher MJ, Yan L, Siegel R, Sachs GS. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biological Psychiatry. 57: 1467-73. PMID 15950022 DOI: 10.1016/J.Biopsych.2005.01.036  0.632
2005 Simon NM, Otto MW, Fischmann D, Racette S, Nierenberg AA, Pollack MH, Smoller JW. Panic disorder and bipolar disorder: anxiety sensitivity as a potential mediator of panic during manic states. Journal of Affective Disorders. 87: 101-5. PMID 15894380 DOI: 10.1016/J.Jad.2005.02.004  0.63
2005 Hinton DE, Pich V, Chhean D, Pollack MH. 'The ghost pushes you down': sleep paralysis-type panic attacks in a Khmer refugee population. Transcultural Psychiatry. 42: 46-77. PMID 15881268 DOI: 10.1177/1363461505050710  0.309
2005 Pollack MH. The pharmacotherapy of panic disorder Journal of Clinical Psychiatry. 66: 23-27. PMID 15842184  0.433
2005 Biederman J, Petty C, Faraone SV, Hirshfeld-Becker DR, Henin A, Pollack MH, Rosenbaum JF. Patterns of comorbidity in panic disorder and major depression: findings from a nonreferred sample. Depression and Anxiety. 21: 55-60. PMID 15816058 DOI: 10.1002/Da.20055  0.483
2005 Hinton DE, Pham T, Tran M, Safren SA, Otto MW, Pollack MH. CBT for Vietnamese refugees with treatment-resistant PTSD and panic attacks: a pilot study. Journal of Traumatic Stress. 17: 429-33. PMID 15633922 DOI: 10.1023/B:Jots.0000048956.03529.Fa  0.434
2005 Worthington JJ, Kinrys G, Wygant LE, Pollack MH. Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients. International Clinical Psychopharmacology. 20: 9-11. PMID 15602109 DOI: 10.1097/00004850-200501000-00002  0.52
2005 Stein MB, Pollack MH, Bystritsky A, Kelsey JE, Mangano RM. Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial. Psychopharmacology. 177: 280-8. PMID 15258718 DOI: 10.1007/S00213-004-1957-9  0.503
2005 Rosenbaum JF, O’Brien CP, Otto MW, Pollack MH, Roy-Byrne PP, Stewart SA. Academic Highlights: Benzodiazepines: Revisiting Clinical Issues in Treating Anxiety Disorders The Primary Care Companion to the Journal of Clinical Psychiatry. 7: 23-30. DOI: 10.4088/Pcc.V07N0104  0.505
2005 Pollack MH. The pharmacotherapy of panic disorder. The Journal of Clinical Psychiatry. 66: 23-27. DOI: 10.1201/9781420001075-8  0.526
2005 Stevens JC, Pollack MH. Pharmacologic Treatment of Panic Disorder Cns Spectrums. 10: 25-31. DOI: 10.1017/S1092852900026511  0.48
2005 Pollack MH. Panic Disorder: Broadening Conceptualizations and Improving Treatment Cns Spectrums. 10: 4-4. DOI: 10.1017/S1092852900026481  0.516
2005 Hinton DE, Pollack MH, Pich V, Fama JM, Barlow DH. Orthostatically induced panic attacks among Cambodian refugees: Flashbacks, catastrophic cognitions, and associated psychopatholgy Cognitive and Behavioral Practice. 12: 301-311+375. DOI: 10.1016/S1077-7229(05)80052-5  0.331
2004 Simon NM, Otto MW, Wisniewski SR, Fossey M, Sagduyu K, Frank E, Sachs GS, Nierenberg AA, Thase ME, Pollack MH. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). The American Journal of Psychiatry. 161: 2222-9. PMID 15569893 DOI: 10.1176/Appi.Ajp.161.12.2222  0.681
2004 Otto MW, Perlman CA, Wernicke R, Reese HE, Bauer MS, Pollack MH. Posttraumatic stress disorder in patients with bipolar disorder: a review of prevalence, correlates, and treatment strategies. Bipolar Disorders. 6: 470-9. PMID 15541062 DOI: 10.1111/J.1399-5618.2004.00151.X  0.494
2004 Hinton DE, Pich V, Chhean D, Pollack MH, Barlow DH. Olfactory-triggered panic attacks among Cambodian refugees attending a psychiatric clinic. General Hospital Psychiatry. 26: 390-7. PMID 15474639 DOI: 10.1016/J.Genhosppsych.2004.04.007  0.393
2004 Hinton D, Pich V, Chhean D, Pollack M. Olfactory-triggered panic attacks among Khmer refugees: a contextual approach. Transcultural Psychiatry. 41: 155-99. PMID 15446720 DOI: 10.1177/1363461504043564  0.309
2004 Simon NM, Otto MW, Smits JA, Nicolaou DC, Reese HE, Pollack MH. Changes in anxiety sensitivity with pharmacotherapy for panic disorder. Journal of Psychiatric Research. 38: 491-5. PMID 15380399 DOI: 10.1016/J.Jpsychires.2004.01.004  0.704
2004 Simon NM, Worthington JJ, Doyle AC, Hoge EA, Kinrys G, Fischmann D, Link N, Pollack MH. An open-label study of levetiracetam for the treatment of social anxiety disorder. The Journal of Clinical Psychiatry. 65: 1219-22. PMID 15367048 DOI: 10.4088/Jcp.V65N0909  0.676
2004 Simon NM, Otto MW, Weiss RD, Bauer MS, Miyahara S, Wisniewski SR, Thase ME, Kogan J, Frank E, Nierenberg AA, Calabrese JR, Sachs GS, Pollack MH. Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. Journal of Clinical Psychopharmacology. 24: 512-20. PMID 15349007 DOI: 10.1097/01.Jcp.0000138772.40515.70  0.682
2004 Pande AC, Feltner DE, Jefferson JW, Davidson JR, Pollack M, Stein MB, Lydiard RB, Futterer R, Robinson P, Slomkowski M, DuBoff E, Phelps M, Janney CA, Werth JL. Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. Journal of Clinical Psychopharmacology. 24: 141-9. PMID 15206660 DOI: 10.1097/01.Jcp.0000117423.05703.E7  0.451
2004 Biederman J, Petty C, Faraone SV, Hirshfeld-Becker D, Pollack MH, Henin A, Gilbert J, Rosenbaum JF. Moderating effects of major depression on patterns of comorbidity in patients with panic disorder. Psychiatry Research. 126: 143-9. PMID 15123393 DOI: 10.1016/J.Psychres.2004.02.001  0.496
2004 Doyle A, Pollack MH. Long-term management of panic disorder. The Journal of Clinical Psychiatry. 24-8. PMID 15078115  0.357
2004 Pollack MH, Allgulander C, Bandelow B, Cassano GB, Greist JH, Hollander E, Nutt DJ, Okasha A, Swinson RP. WCA recommendations for the long-term treatment of panic disorder. Cns Spectrums. 8: 17-30. PMID 14767395 DOI: 10.1017/S109285290000691X  0.549
2004 Otto MW, Safren SA, Pollack MH. Internal cue exposure and the treatment of substance use disorders: lessons from the treatment of panic disorder. Journal of Anxiety Disorders. 18: 69-87. PMID 14725869 DOI: 10.1016/J.Janxdis.2003.07.007  0.482
2004 Doyle AC, Pollack MH. Establishment of remission criteria for anxiety disorders. The Journal of Clinical Psychiatry. 40-5. PMID 14658990  0.475
2004 Pollack MH, Doyle AC. Treatment of panic disorder: focus on paroxetine. Psychopharmacology Bulletin. 53-63. PMID 14566201  0.439
2004 Otto MW, Hinton D, Korbly NB, Chea A, Ba P, Gershuny BS, Pollack MH. Treatment of pharmacotherapy-refractory posttraumatic stress disorder among Cambodian refugees: a pilot study of combination treatment with cognitive-behavior therapy vs sertraline alone. Behaviour Research and Therapy. 41: 1271-6. PMID 14527527 DOI: 10.1016/S0005-7967(03)00032-9  0.43
2004 Marzol PC, Pollack MH. New developments in panic disorder. Current Psychiatry Reports. 2: 353-7. PMID 11122981 DOI: 10.1007/S11920-000-0081-8  0.518
2004 Hinton D, So V, Pollack MH, Pitman RK, Orr SP. The Psychophysiology of Orthostatic Panic in Cambodian Refugees Attending a Psychiatric Clinic Journal of Psychopathology and Behavioral Assessment. 26: 1-13. DOI: 10.1023/B:Joba.0000007451.85942.42  0.454
2004 Pollack MH. Pharmacologic Treatments for Anxiety Cns Spectrums. 9: 4-8. DOI: 10.1017/S1092852900027103  0.55
2004 Pollack MH, Stein MB, Davidson JR, Ginsberg DL. New Challenges for Anxiety Disorders: Where Treatment, Resilience, and Economic Priority Converge Cns Spectrums. 9: 1-4. DOI: 10.1017/S1092852900027097  0.527
2004 Pollack M, Kasper S, Cohn C, Farfel G, Zornberg G. P.3.038 Efficacy of pregabalin in clinically relevantsubtypes of generalized anxiety disorder European Neuropsychopharmacology. 14: S320. DOI: 10.1016/S0924-977X(04)80418-8  0.383
2003 Simon NM, Emmanuel N, Ballenger J, Worthington JJ, Kinrys G, Korbly NB, Farach FJ, Pollack MH. Bupropion sustained release for panic disorder. Psychopharmacology Bulletin. 37: 66-72. PMID 15131517  0.637
2003 Allgulander C, Bandelow B, Hollander E, Montgomery SA, Nutt DJ, Okasha A, Pollack MH, Stein DJ, Swinson RP. WCA recommendations for the long-term treatment of generalized anxiety disorder. Cns Spectrums. 8: 53-61. PMID 14767398 DOI: 10.1017/S1092852900006945  0.46
2003 Van Ameringen M, Allgulander C, Bandelow B, Greist JH, Hollander E, Montgomery SA, Nutt DJ, Okasha A, Pollack MH, Stein DJ, Swinson RP. WCA recommendations for the long-term treatment of social phobia. Cns Spectrums. 8: 40-52. PMID 14767397 DOI: 10.1017/S1092852900006933  0.463
2003 Stein DJ, Bandelow B, Hollander E, Nutt DJ, Okasha A, Pollack MH, Swinson RP, Zohar J. WCA Recommendations for the long-term treatment of posttraumatic stress disorder. Cns Spectrums. 8: 31-9. PMID 14767396 DOI: 10.1017/S1092852900006921  0.454
2003 Blais MA, Holdwick DJ, McLean RY, Otto MW, Pollack MH, Hilsenroth MJ. Exploring the psychometric properties and construct validity of the MCMI-III anxiety and avoidant personality scales. Journal of Personality Assessment. 81: 237-41. PMID 14638448 DOI: 10.1207/S15327752Jpa8103_06  0.413
2003 Pollack MH, Simon NM, Worthington JJ, Doyle AL, Peters P, Toshkov F, Otto MW. Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder. Journal of Psychopharmacology (Oxford, England). 17: 276-82. PMID 14513919 DOI: 10.1177/02698811030173009  0.613
2003 Manfro GG, Isolan L, Blaya C, Maltz S, Heldt E, Pollack MH. Relationship between adult social phobia and childhood anxiety. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). 25: 96-9. PMID 12975706 DOI: 10.1590/S1516-44462003000200009  0.469
2003 Pollack MH, Meoni P, Otto MW, Simon N, Hackett D. Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety disorder: a pooled analysis of short- and long-term studies. Journal of Clinical Psychopharmacology. 23: 250-9. PMID 12826987 DOI: 10.1097/01.Jcp.0000084025.22282.84  0.619
2003 Huffman JC, Pollack MH. Predicting panic disorder among patients with chest pain: an analysis of the literature. Psychosomatics. 44: 222-36. PMID 12724504 DOI: 10.1176/Appi.Psy.44.3.222  0.405
2003 Manfro GG, Alexandre Netto C, Pollack M, Mezzomo KM, Preffer F, Kradin R. Stress regulates the lymphocyte homing receptor CD62L (L-selectin). Arquivos De Neuro-Psiquiatria. 61: 20-4. PMID 12715014 DOI: 10.1590/S0004-282X2003000100004  0.316
2003 Kinrys G, Pollack MH, Simon NM, Worthington JJ, Nardi AE, Versiani M. Valproic acid for the treatment of social anxiety disorder. International Clinical Psychopharmacology. 18: 169-72. PMID 12702897 DOI: 10.1097/01.Yic.0000064261.66765.9F  0.645
2003 Roy-Byrne P, Russo J, Pollack M, Stewart R, Bystrisky A, Bell J, Rosenbaum J, Corrigan MH, Stolk J, Rush AJ, Ballenger J. Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder. Psychological Medicine. 33: 511-8. PMID 12701671 DOI: 10.1017/S0033291703007402  0.475
2003 Hagengimana A, Hinton D, Bird B, Pollack M, Pitman RK. Somatic panic-attack equivalents in a community sample of Rwandan widows who survived the 1994 genocide. Psychiatry Research. 117: 1-9. PMID 12581815 DOI: 10.1016/S0165-1781(02)00301-3  0.5
2003 Hackett D, Stein M, Mangano R, Pollack M. P.3.063 Long-term treatment of generalized social anxiety disorder with venlafaxine XR European Neuropsychopharmacology. 13: S380-S381. DOI: 10.1016/S0924-977X(03)92183-3  0.466
2002 Simon NM, Korbly NB, Worthington JJ, Kinrys G, Pollack MH. Citalopram for social anxiety disorder: an open-label pilot study in refractory and nonrefractory patients. Cns Spectrums. 7: 655-7. PMID 15097929 DOI: 10.1017/S1092852900022148  0.685
2002 Pollack MH. New advances in the management of anxiety disorders Psychopharmacology Bulletin. 36: 79-94. PMID 12858146  0.469
2002 Worthington JJ, Simon NM, Korbly NB, Perlis RH, Pollack MH. Ropinirole for antidepressant-induced sexual dysfunction. International Clinical Psychopharmacology. 17: 307-10. PMID 12409684 DOI: 10.1097/00004850-200211000-00006  0.51
2002 Pollack MH, Rapaport MH, Fayyad R, Otto MW, Nierenberg AA, Clary CM. Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder. Journal of Psychiatric Research. 36: 229-36. PMID 12191627 DOI: 10.1016/S0022-3956(02)00010-9  0.493
2002 Safren SA, Gershuny BS, Marzol P, Otto MW, Pollack MH. History of childhood abuse in panic disorder, social phobia, and generalized anxiety disorder. The Journal of Nervous and Mental Disease. 190: 453-6. PMID 12142846 DOI: 10.1097/00005053-200207000-00005  0.528
2002 Simon NM, Blacker D, Korbly NB, Sharma SG, Worthington JJ, Otto MW, Pollack MH. Hypothyroidism and hyperthyroidism in anxiety disorders revisited: new data and literature review. Journal of Affective Disorders. 69: 209-17. PMID 12103468 DOI: 10.1016/S0165-0327(01)00378-0  0.66
2002 Simon NM, Safren SA, Otto MW, Sharma SG, Lanka GD, Pollack MH. Longitudinal outcome with pharmacotherapy in a naturalistic study of panic disorder. Journal of Affective Disorders. 69: 201-8. PMID 12103467 DOI: 10.1016/S0165-0327(01)00359-7  0.641
2002 Simon NM, Otto MW, Korbly NB, Peters PM, Nicolaou DC, Pollack MH. Quality of life in social anxiety disorder compared with panic disorder and the general population. Psychiatric Services (Washington, D.C.). 53: 714-8. PMID 12045308 DOI: 10.1176/Appi.Ps.53.6.714  0.665
2002 Pollack MH, Zaninelli R, McCafferty JP, Bellew KM, Burnham DB, Iyengar MK, Goddard A. Reply to "Surprising Results in the Study of Paroxetine for Generalized Anxiety Disorder" The Journal of Clinical Psychiatry. 63: 536-537. DOI: 10.4088/Jcp.V63N0612E  0.527
2002 Pollack M, Bose A, Zheng H. Efficacy and tolerability of escitalopram in the treatment of anxiety disorders European Neuropsychopharmacology. 12: 344. DOI: 10.1016/S0924-977X(02)80541-7  0.432
2001 Otto MW, Pollack MH, Maki KM, Gould RA, Worthington JJ, Smoller JW, Rosenbaum JF. Childhood history of anxiety disorders among adults with social phobia: rates, correlates, and comparisons with patients with panic disorder. Depression and Anxiety. 14: 209-13. PMID 11754127 DOI: 10.1002/da.1068  0.444
2001 Otto MW, Tuby KS, Gould RA, McLean RY, Pollack MH. An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder. The American Journal of Psychiatry. 158: 1989-92. PMID 11729014 DOI: 10.1176/Appi.Ajp.158.12.1989  0.393
2001 Rapaport MH, Wolkow R, Rubin A, Hackett E, Pollack M, Ota KY. Sertraline treatment of panic disorder: results of a long-term study. Acta Psychiatrica Scandinavica. 104: 289-98. PMID 11722304 DOI: 10.1034/J.1600-0447.2001.00263.X  0.437
2001 Blais MA, Otto MW, Zucker BG, McNally RJ, Schmidt NB, Fava M, Pollack MH. The anxiety sensitivity index: item analysis and suggestions for refinement. Journal of Personality Assessment. 77: 272-94. PMID 11693859 DOI: 10.1207/S15327752Jpa7702_10  0.364
2001 Simon NM, Sharma SG, Worthington JJ, Marzol PC, Pollack MH. Citalopram for social phobia: a clinical case series. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 25: 1469-74. PMID 11513360 DOI: 10.1016/S0278-5846(01)00189-0  0.645
2001 Safren SA, Lanka GD, Otto MW, Pollack MH. Prevalence of childhood ADHD among patients with Generalized Anxiety Disorder and a comparison condition, Social Phobia. Depression and Anxiety. 13: 190-1. PMID 11413566 DOI: 10.1002/Da.1036  0.465
2001 Katherine Shear M, Bilt JV, Rucci P, Endicott J, Lydiard B, Otto MW, Pollack MH, Chandler L, Williams J, Ali A, Frank DM. Reliability and validity of a Structured Interview Guide for the Hamilton Anxiety Rating Scale (SIGH-A) Depression and Anxiety. 13: 166-178. PMID 11413563 DOI: 10.1002/Da.1033  0.374
2001 Pollack MH, Zaninelli R, Goddard A, McCafferty JP, Bellew KM, Burnham DB, Iyengar MK. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial. The Journal of Clinical Psychiatry. 62: 350-7. PMID 11411817 DOI: 10.4088/Jcp.V62N0508  0.493
2001 Smoller JW, Acierno JS, Rosenbaum JF, Biederman J, Pollack MH, Meminger S, Pava JA, Chadwick LH, White C, Bulzacchelli M, Slaugenhaupt SA. Targeted genome screen of panic disorder and anxiety disorder proneness using homology to murine QTL regions. American Journal of Medical Genetics. 105: 195-206. PMID 11304837 DOI: 10.1002/Ajmg.1209  0.415
2001 Rapaport MH, Pollack MH, Clary CM, Mardekian J, Wolkow R. Panic disorder and response to sertraline: The effect of previous treatment with benzodiazepines Journal of Clinical Psychopharmacology. 21: 104-107. PMID 11199932 DOI: 10.1097/00004714-200102000-00019  0.471
2001 Uhlenhuth EH, Matuzas W, Warner TD, Paine S, Lydiard RB, Pollack MH. Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replication. Journal of Clinical Psychopharmacology. 20: 622-7. PMID 11106133 DOI: 10.1097/00004714-200012000-00007  0.44
2000 Otto MW, Pollack MH, Gould RA, Worthington JJ, McArdle ET, Rosenbaum JF. A comparison of the efficacy of clonazepam and cognitive-behavioral group therapy for the treatment of social phobia. Journal of Anxiety Disorders. 14: 345-58. PMID 11043885 DOI: 10.1016/S0887-6185(00)00027-X  0.465
2000 Pande AC, Pollack MH, Crockatt J, Greiner M, Chouinard G, Lydiard RB, Taylor CB, Dager SR, Shiovitz T. Placebo-controlled study of gabapentin treatment of panic disorder. Journal of Clinical Psychopharmacology. 20: 467-71. PMID 10917408 DOI: 10.1097/00004714-200008000-00011  0.45
2000 Pollack MH, Marzol PC. Panic: course, complications and treatment of panic disorder. Journal of Psychopharmacology (Oxford, England). 14: S25-30. PMID 10888028 DOI: 10.1177/02698811000142S104  0.558
2000 Rapaport MH, Pollack M, Wolkow R, Mardekian J, Clary C. Is placebo response the same as drug response in panic disorder? American Journal of Psychiatry. 157: 1014-1016. PMID 10831487 DOI: 10.1176/Appi.Ajp.157.6.1014  0.471
2000 Rickels K, Pollack MH, Sheehan DV, Haskins JT. Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder. The American Journal of Psychiatry. 157: 968-74. PMID 10831478 DOI: 10.1176/appi.ajp.157.6.968  0.383
2000 Fones CS, Pollack MH, Susswein L, Otto M. History of childhood attention deficit hyperactivity disorder (ADHD) features among adults with panic disorder. Journal of Affective Disorders. 58: 99-106. PMID 10781699 DOI: 10.1016/S0165-0327(99)00065-8  0.389
2000 Manfro GG, Pollack MH, Otto MW, Worthington JJ, Rosenbaum JF, Scott EL, Kradin RL. Cell-surface expression of L-selectin (CD62L) by blood lymphocytes: correlates with affective parameters and severity of panic disorder. Depression and Anxiety. 11: 31-7. PMID 10723633 DOI: 10.1002/(SICI)1520-6394(2000)11:1<31::AID-DA5>3.0.CO;2-O  0.31
2000 Pollack MH, Rapaport MH, Clary CM, Mardekian J, Wolkow R. Sertraline Treatment of Panic Disorder The Journal of Clinical Psychiatry. 61: 922-927. DOI: 10.4088/Jcp.V61N1206  0.481
2000 Simon NM, Pollack MH. The Current Status of the Treatment of Panic Disorder: Pharmacotherapy and Cognitive-Behavioral Therapy Psychiatric Annals. 30: 689-696. DOI: 10.3928/0048-5713-20001101-06  0.61
2000 Simon NM, Pollack MH. Anxiety Disorders: Current Conceptualizations and Future Directions Psychiatric Annals. 30: 676-676. DOI: 10.3928/0048-5713-20001101-04  0.659
2000 Otto MW, Pollack MH, Maki KM. Empirically supported treatments for panic disorder: Costs, benefits, and stepped care. Journal of Consulting and Clinical Psychology. 68: 556-563. DOI: 10.1037/0022-006X.68.4.556  0.375
2000 Feltner D, Pollack M, Davidson J, Stein M, Futterer R, Jefferson J, Lydiard R, DuBoff E, Robinson P, Phelps M, Slomkowski M, Werth J, Pande A. A placebo-controlled, double-blind study of pregabalin treatment of social phobia: Outcome and predictors of response European Neuropsychopharmacology. 10: 344-345. DOI: 10.1016/S0924-977X(00)80439-3  0.325
1999 Scott EL, Pollack MH, Otto MW, Simon NM, Worthington JJ. Clinician response to treatment refractory panic disorder: a survey of psychiatrists. The Journal of Nervous and Mental Disease. 187: 755-7. PMID 10665472 DOI: 10.1097/00005053-199912000-00009  0.652
1999 McNally RJ, Otto MW, Yap L, Pollack MH, Hornig CD. Is panic disorder linked to cognitive avoidance of threatening information? Journal of Anxiety Disorders. 13: 335-48. PMID 10504105 DOI: 10.1016/S0887-6185(99)00008-0  0.377
1999 Otto MW, Pollack MH, Penava SJ, Zucker BG. Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series. Behaviour Research and Therapy. 37: 763-70. PMID 10452176 DOI: 10.1016/S0005-7967(98)00176-4  0.411
1999 Michelson D, Pollack M, Lydiard RB, Tamura R, Tepner R, Tollefson G. Continuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine. The Fluoxetine Panic Disorder Study Group. The British Journal of Psychiatry : the Journal of Mental Science. 174: 213-8. PMID 10448445 DOI: 10.1192/Bjp.174.3.213  0.5
1999 Candilis PJ, McLean RY, Otto MW, Manfro GG, Worthington JJ, Penava SJ, Marzol PC, Pollack MH. Quality of life in patients with panic disorder. The Journal of Nervous and Mental Disease. 187: 429-34. PMID 10426463 DOI: 10.1097/00005053-199907000-00006  0.493
1999 Smoller JW, Simon NM, Pollack MH, Kradin R, Stern T. Anxiety in patients with pulmonary disease: comorbidity and treatment. Seminars in Clinical Neuropsychiatry. 4: 84-97. PMID 10378952 DOI: 10.1053/SCNP00400084  0.6
1999 Stein MB, Fyer AJ, Davidson JR, Pollack MH, Wiita B. Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study. The American Journal of Psychiatry. 156: 756-60. PMID 10327910 DOI: 10.1176/Ajp.156.5.756  0.455
1998 Worthington JJ, Zucker BG, Fones CS, Otto MW, Pollack MH. Nefazodone for social phobia: a clinical case series. Depression and Anxiety. 8: 131-3. PMID 9836065 DOI: 10.1002/(Sici)1520-6394(1998)8:3<131::Aid-Da6>3.0.Co;2-G  0.391
1998 Pollack MH, Otto MW, Worthington JJ, Manfro GG, Wolkow R. Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial. Archives of General Psychiatry. 55: 1010-6. PMID 9819070 DOI: 10.1001/Archpsyc.55.11.1010  0.483
1998 Michelson D, Lydiard RB, Pollack MH, Tamura RN, Hoog SL, Tepner R, Demitrack MA, Tollefson GD. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group. The American Journal of Psychiatry. 155: 1570-7. PMID 9812120 DOI: 10.1176/Ajp.155.11.1570  0.515
1998 Penava SJ, Otto MW, Maki KM, Pollack MH. Rate of improvement during cognitive-behavioral group treatment for panic disorder. Behaviour Research and Therapy. 36: 665-73. PMID 9682523 DOI: 10.1016/S0005-7967(98)00035-7  0.453
1998 Simon NM, Pollack MH, Tuby KS, Stern TA. Dizziness and panic disorder: a review of the association between vestibular dysfunction and anxiety. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 10: 75-80. PMID 9669539 DOI: 10.1023/A:1026167000066  0.68
1998 Pollack MH, Matthews J, Scott EL. Gabapentin as a potential treatment for anxiety disorders. The American Journal of Psychiatry. 155: 992-3. PMID 9659873 DOI: 10.1176/Ajp.155.7.992  0.535
1998 Otto MW, Demopulos CM, McLean NE, Pollack MH, Fava M. Additional findings on the association between anxiety sensitivity and hypochondriacal concerns: examination of patients with major depression. Journal of Anxiety Disorders. 12: 225-32. PMID 9653681 DOI: 10.1016/S0887-6185(98)00011-5  0.488
1998 Smoller JW, Pollack MH, Systrom D, Kradin RL. Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics. 39: 24-9. PMID 9538672 DOI: 10.1016/S0033-3182(98)71377-5  0.395
1998 Labbate LA, Grimes JB, Hines A, Pollack MH. Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 9: 241-5. PMID 9511948 DOI: 10.1023/A:1022356427242  0.318
1998 Fones CS, Manfro GG, Pollack MH. Social phobia: an update. Harvard Review of Psychiatry. 5: 247-59. PMID 9493947 DOI: 10.3109/10673229809000308  0.489
1998 Candilis PJ, Pollack MH. The hidden costs of untreated anxiety disorders. Harvard Review of Psychiatry. 5: 40-2. PMID 9385019 DOI: 10.3109/10673229709034724  0.462
1998 Otto MW, Pollack MH. Treatment strategies for panic disorder: a debate. Harvard Review of Psychiatry. 2: 166-70. PMID 9384898 DOI: 10.3109/10673229409017133  0.453
1998 Simon N, Pollack M, Tuby K, Stern T. Dizziness and Panic Disorder: a Review of the Association Between Vestibular Dysfunction and Anxiety Annals of Clinical Psychiatry. 10: 75-80. DOI: 10.3109/10401239809147746  0.619
1998 Pollack M, Rapaport M, Clary C, Wolkow R, Mardekian J, Otto M, Nierenberg A. Early response to sertraline as a predictor of 12-week outcome in panic disorder European Neuropsychopharmacology. 8: S257. DOI: 10.1016/S0924-977X(98)80464-1  0.423
1998 Michelson D, Lydiard R, Pollack M, Tamura R, Tepner R, Tollefson G. Fluoxetine treatment of panic disorder: A randomized, placebo-controlled, multi-center trial European Psychiatry. 13: 284s-284s. DOI: 10.1016/S0924-9338(99)80548-3  0.437
1998 Michelson D, Lydiard R, Pollack M, Tamura R, Tepner R, Tollefson G. Long-term treatment in panic disorder: Randomization of acute fluoxetine responders to continued treatment with fluoxetine or placebo European Psychiatry. 13: 284s-284s. DOI: 10.1016/S0006-3223(98)90754-5  0.465
1998 Michelson D, Lydiard R, Pollack M, Tamura R, Tepner R, Tollefson G. 306. Long-term treatment in panic disorder: Randomization of acute fluoxetine responders to continued treatment with fluoxetine or placebo Biological Psychiatry. 43: S92. DOI: 10.1016/S0006-3223(98)90754-5  0.311
1998 Michelson D, Lydiard R, Pollack M, Tamura R, Tepner R. 305. Fluoxetine treatment of panic disorder: A randomized, placebo-controlled, multi-center trial Biological Psychiatry. 43: S91-S92. DOI: 10.1016/S0006-3223(98)90753-3  0.437
1997 Wilhelm S, Otto MW, Zucker BG, Pollack MH. Prevalence of body dysmorphic disorder in patients with anxiety disorders. Journal of Anxiety Disorders. 11: 499-502. PMID 9407269 DOI: 10.1016/S0887-6185(97)00026-1  0.53
1997 Noyes R, Moroz G, Davidson JRT, Liebowitz MR, Davidson A, Siegel J, Bell J, Cain JW, Curlik SM, Kent TA, Bruce Lydiard R, Mallinger AG, Pollack MH, Rapaport M, Rasmussen SA, et al. Moclobemide in social phobia: A controlled dose-response trial Journal of Clinical Psychopharmacology. 17: 247-254. PMID 9241002 DOI: 10.1097/00004714-199708000-00002  0.311
1997 McNally RJ, Hornig CD, Otto MW, Pollack MH. Selective encoding of threat in panic disorder: application of a dual priming paradigm. Behaviour Research and Therapy. 35: 543-9. PMID 9159978 DOI: 10.1016/S0005-7967(96)00125-8  0.42
1997 Worthington JJ, Pollack MH, Otto MW, Gould RA, Sabatino SA, Goldman L, Rosenbaum JF, Lee TH. Panic disorder in emergency ward patients with chest pain. The Journal of Nervous and Mental Disease. 185: 274-6. PMID 9114814 DOI: 10.1097/00005053-199704000-00009  0.379
1997 Gould RA, Buckminster S, Pollack MH, Otto MW, Massachusetts LY. Cognitive-Behavioral and Pharmacological Treatment for Social Phobia: A Meta-Analysis Clinical Psychology: Science and Practice. 4: 291-306. DOI: 10.1111/J.1468-2850.1997.Tb00123.X  0.341
1997 Pollack MH, Scott EL. Gabapentin and lamotrigine: Novel treatments for mood and anxiety disorders Cns Spectrums. 2: 56-61. DOI: 10.1017/S1092852900011093  0.536
1997 Lydiard R, Pollack M, Judge R, Michelson D, Tamura R. P.3.055 Fluoxetine in panic disorder: A placebo-controlled study European Neuropsychopharmacology. 7: S243. DOI: 10.1016/S0924-977X(97)88802-5  0.447
1997 Pollack M, Wolkow R, Clary C. Multi-dimensional outcome and quality of life in panic disorder: The effects of sertraline treatment Biological Psychiatry. 42: 248S. DOI: 10.1016/S0006-3223(97)87941-3  0.397
1997 Gould RA, Otto MW, Pollack MH, Yap L. Cognitive behavioral and pharmacological treatment of generalized anxiety disorder: A preliminary meta-analysis Behavior Therapy. 28: 285-305. DOI: 10.1016/S0005-7894(97)80048-2  0.463
1996 Manfro GG, Otto MW, McArdle ET, Worthington JJ, Rosenbaum JF, Pollack MH. Relationship of antecedent stressful life events to childhood and family history of anxiety and the course of panic disorder. Journal of Affective Disorders. 41: 135-9. PMID 8961041 DOI: 10.1016/S0165-0327(96)00081-X  0.497
1996 Pollack MH, Gould RA. The pharmacotherapy of social phobia. International Clinical Psychopharmacology. 11: 71-5. PMID 8923113 DOI: 10.1097/00004850-199606003-00012  0.338
1996 Gould RA, Ball S, Kaspi SP, Otto MW, Pollack MH, Shekhar A, Fava M. Prevalence and correlates of anger attacks: a two site study. Journal of Affective Disorders. 39: 31-8. PMID 8835651 DOI: 10.1016/0165-0327(96)00017-1  0.498
1996 Smoller JW, Pollack MH, Otto MW, Rosenbaum JF, Kradin RL. Panic anxiety, dyspnea, and respiratory disease. Theoretical and clinical considerations. American Journal of Respiratory and Critical Care Medicine. 154: 6-17. PMID 8680700 DOI: 10.1164/Ajrccm.154.1.8680700  0.399
1996 Worthington JJ, Pollack MH. Treatment of dysphoric mania with nefazodone. The American Journal of Psychiatry. 153: 732-3. PMID 8615426 DOI: 10.1176/Ajp.153.5.732B  0.301
1996 Pollack MH, Otto MW, Sabatino S, Majcher D, Worthington JJ, McArdle ET, Rosenbaum JF. Relationship of childhood anxiety to adult panic disorder: correlates and influence on course. The American Journal of Psychiatry. 153: 376-81. PMID 8610825 DOI: 10.1176/ajp.153.3.376  0.43
1996 Geller JL, Pollack MH. Handbook of Depression and Anxiety: A Biological Approach Psychiatric Services. 47: 1403-1403. DOI: 10.1176/Ps.47.12.1403  0.329
1996 Otto MW, Pollack MH, Sabatino SA. Maintenance of remission following cognitive behavior therapy for panic disorder: Possible deleterious effects of concurrent medication treatment Behavior Therapy. 27: 473-482. DOI: 10.1016/S0005-7894(96)80028-1  0.481
1996 Wolkow R, Apter J, Clayton A, Coryell W, Cunningham L, McEntee W, O’Hair D, Pollack M, Rausch J, Stewart R, Weisler R. Double-blind flexible dose study of sertraline and placebo in patients with panic disorder European Neuropsychopharmacology. 6: 113. DOI: 10.1016/0924-977X(96)87823-0  0.44
1995 Pollack MH, Smoller JW. The Longitudinal Course and Outcome of Panic Disorder Psychiatric Clinics of North America. 18: 785-801. DOI: 10.1016/S0193-953X(18)30023-6  0.419
1995 Otto MW, Pollack MH, Gould RA, Sabatino SA. P-5-32 Maintenance of remission in panic disorder: Issues for cognitive-behavior therapy, pharmacotherapy, and their combination European Neuropsychopharmacology. 5: 363-364. DOI: 10.1016/0924-977X(95)90636-R  0.399
1995 Pollack M, Otto M, Sabatino S, McCardle E, Rosenbaum J. P-5-17 Predictors of time to relapse in a longitudinal study of panic disorder European Neuropsychopharmacology. 5: 358-359. DOI: 10.1016/0924-977X(95)90621-J  0.447
1995 Otto MW, Pollack MH, Fava M, Uccello R, Rosenbaum JF. Elevated Anxiety Sensitivity Index scores in patients with major depression: Correlates and changes with antidepressant treatment Journal of Anxiety Disorders. 9: 117-123. DOI: 10.1016/0887-6185(94)00035-2  0.518
1995 Gould RA, Ott MW, Pollack MH. A meta-analysis of treatment outcome for panic disorder Clinical Psychology Review. 15: 819-844. DOI: 10.1016/0272-7358(95)00048-8  0.331
1995 Ball SG, Otto MW, Pollack MH, Uccello R, Rosenbaum JF. Differentiating social phobia and panic disorder: A test of core beliefs Cognitive Therapy and Research. 19: 473-482. DOI: 10.1007/Bf02230413  0.507
1994 Otto MW, Pollack MH, Rosenbaum JF, Sachs GS, Asher RH. Childhood history of anxiety in adults with panic disorder: association with anxiety sensitivity and comorbidity. Harvard Review of Psychiatry. 1: 288-93. PMID 9384860 DOI: 10.3109/10673229409017091  0.539
1994 Ball SG, Otto MW, Pollack MH, Rosenbaum JF. Predicting prospective episodes of depression in patients with panic disorder: a longitudinal study. Journal of Consulting and Clinical Psychology. 62: 359-65. PMID 8201074 DOI: 10.1037//0022-006X.62.2.359  0.431
1994 Labbate LA, Pollack MH, Otto MW, Langenauer S, Rosenbaum JF. Sleep panic attacks: an association with childhood anxiety and adult psychopathology. Biological Psychiatry. 36: 57-60. PMID 8080905 DOI: 10.1016/0006-3223(94)90063-9  0.5
1994 Pollack MH, Otto MW, Sachs GS, Leon A, Shear MK, Deltito JA, Keller MB, Rosenbaum JF. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo. Journal of Affective Disorders. 30: 273-81. PMID 8014326 DOI: 10.1016/0165-0327(94)90134-1  0.462
1994 Otto MW, McNally RJ, Pollack MH, Chen E, Rosenbaum JF. Hemispheric laterality and memory bias for threat in anxiety disorders. Journal of Abnormal Psychology. 103: 828-31. PMID 7822587 DOI: 10.1037/0021-843X.103.4.828  0.378
1994 Otto MW, Gould RA, Pollack MH. Cognitive-Behavioral Treatment of Panic Disorder: Considerations for the Treatment of Patients Over the Long Term Psychiatric Annals. 24: 307-315. DOI: 10.3928/0048-5713-19940601-10  0.423
1994 Pollack MH, Otto MW. Long-Term Pharmacologic Treatment of Panic Disorder Psychiatric Annals. 24: 291-298. DOI: 10.3928/0048-5713-19940601-08  0.441
1994 Otto MW, Pollack MH. Panic disorder and hypochondriacal concerns: A reply to Taylor Journal of Anxiety Disorders. 8: 101-103. DOI: 10.1016/0887-6185(94)90027-2  0.432
1994 Kaspi SP, Otto MW, Pollack MH, Eppinger S, Rosenbaum JF. Premenstrual exacerbation of symptoms in women with panic disorder Journal of Anxiety Disorders. 8: 131-138. DOI: 10.1016/0887-6185(94)90011-6  0.399
1993 Otto MW, Pollack MH, Sachs GS, Reiter SR, Meltzer-Brody S, Rosenbaum JF. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. The American Journal of Psychiatry. 150: 1485-90. PMID 8379551 DOI: 10.1176/Ajp.150.10.1485  0.494
1993 Keller MB, Lavori PW, Goldenberg IM, Baker LA, Pollack MH, Sachs GS, Rosenbaum JF, Deltito JA, Leon A, Shear K. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo. Journal of Affective Disorders. 28: 27-38. PMID 8326078 DOI: 10.1016/0165-0327(93)90074-T  0.428
1993 Pollack MH, Stern TA. Recognition and Management of Anxiety in the Intensive Care Unit Journal of Intensive Care Medicine. 8: 1-15. DOI: 10.1177/088506669300800101  0.396
1993 POLLACK MH, OTTO MW, TESAR GE, COHEN LS, MELTZER-BRODY S, ROSENBAUM JF. Long-term Outcome After Acute Treatment with Journal of Clinical Psychopharmacology. 13: 257???263. DOI: 10.1097/00004714-199308000-00005  0.474
1992 Otto MW, Pollack MH, Sachs GS, O'Neil CA, Rosenbaum JF. Alcohol dependence in panic disorder patients. Journal of Psychiatric Research. 26: 29-38. PMID 1560407 DOI: 10.1016/0022-3956(92)90013-E  0.385
1992 Pollack MH, Otto MW, Rosenbaum JF, Sachs GS. Personality disorders in patients with panic disorder: association with childhood anxiety disorders, early trauma, comorbidity, and chronicity. Comprehensive Psychiatry. 33: 78-83. PMID 1544300 DOI: 10.1016/0010-440X(92)90002-8  0.531
1992 Otto MW, Pollack MH, Sachs GS, Rosenbaum JF. Hypochondriacal concerns, anxiety sensitivity, and panic disorder Journal of Anxiety Disorders. 6: 93-104. DOI: 10.1016/0887-6185(92)90008-U  0.535
1991 Reiter SR, Otto MW, Pollack MH, Rosenbaum JF. Major depression in panic disorder patients with comorbid social phobia. Journal of Affective Disorders. 22: 171-7. PMID 1918660 DOI: 10.1016/0165-0327(91)90051-S  0.48
1991 Greenberg D, Eisenthal S, Tesar G, Rosenbaum J, Pollack M, Herman J, Sachs G, Cohen L. Linking Panic Disorder and Depression: the Fatigue Dimension Annals of Clinical Psychiatry. 3: 205-208. DOI: 10.3109/10401239109147992  0.493
1990 Rosenbaum JF, Fava M, Falk WE, Pollack MH, Cohen LS, Cohen BM, Zubenko GS. The antidepressant potential of oral S-adenosyl-l-methionine. Acta Psychiatrica Scandinavica. 81: 432-6. PMID 2113347 DOI: 10.1111/J.1600-0447.1990.Tb05476.X  0.312
1989 Fava M, Rosenbaum JF, MacLaughlin RA, Tesar GE, Pollack MH, Cohen LS, Hirsch M. Dehydroepiandrosterone-sulfate/cortisol ratio in panic disorder. Psychiatry Research-Neuroimaging. 28: 345-350. PMID 2527376 DOI: 10.1016/0165-1781(89)90215-1  0.416
1988 Pollack MH, Rosenbaum JF. Benzodiazepines in panic-related disorders Journal of Anxiety Disorders. 2: 95-107. DOI: 10.1016/0887-6185(88)90016-3  0.499
1987 Pollack MH, Rosenbaum JF, Hyman SE. Calcium channel blockers in psychiatry. Psychosomatics. 28: 356-60, 369. PMID 3326023 DOI: 10.1016/S0033-3182(87)72509-2  0.377
1986 POLLACK MH, TESAR GE, ROSENBAUM JF, SPIER SA. Clonazepam in the Treatment of Panic Disorder and Agoraphobia Journal of Clinical Psychopharmacology. 6: 302???304. DOI: 10.1097/00004714-198610000-00010  0.502
Show low-probability matches.